Skip to Content


Long awaited results indicate a statistically significant difference in BIMF scores at day 45 (postpartum); women on Zuranolone were functioning better than those on placebo (on average): “In addition to assessing clinician-rated measures of depression, anxiety, and global function, the patient-reported BIMF scores were assessed for maternal function. Numerically greater increases in BIMF scores were…
Continue Reading